(NASDAQ: XCUR) is trading higher on news of $5million private placement places at premium to market. Money raised to support advancement of pre-clinical candidates.  Shares are up 40% on increasing volume as the stock still trades below a dollar.

(NASDAQ: XCUR) is trading higher on news of $5million private placement places at premium to market. Money raised to support advancement of pre-clinical candidates.  Shares are up 40% on increasing volume as the stock still trades below a dollar.

Exicure Announces $5 Million Raise in Private Placement Transaction Priced at Market Premium

Proceeds expected to support Exicures continued advancement of preclinical candidates including its SCN9A product candidate, a non-opioid pain analgesic


  • The private placement is being led by a subsidiary of CBI Co., Ltd. (CBI), a member of a leading investment group in South Korea focusing on science-based companies in South Korea and the United States

CHICAGO–(BUSINESS WIRE)–
Exicure, Inc. (NASDAQ:XCUR), an early-stage biotechnology company focused on the development of next generation nucleic acid therapies targeting RNA to address both genetic and non-genetic neurological disorders and hair loss disorders, today announced that it has agreed to sell an aggregate of 26,021,111 shares of its common stock at a purchase price of $0.1937 per share to certain accredited investors in a private placement in public equity (PIPE) financing. The purchase price of $0.1937 per share of common stock represents an approximately 45% premium to the 10-day volume weighted-average share price from May 9, 2022. Exicure anticipates that the gross proceeds from the PIPE will be approximately $5 million, before deducting transaction-related expenses payable by the Company. The Company intends to use the net proceeds from this offering to support the development of the advancement of its preclinical program, including the development of its SCN9A product candidate, as well as other working capital and general corporate purposes.

Read entire article here: https://www.businesswire.com/news/home/20220510006499/en/Exicure-Announces-5-Million-Raise-in-Private-Placement-Transaction-Priced-at-Market-Premium

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.